# **Metadata Extraction from Mass Spetrometry Proteomics Publications**

## **Problem Statement**  
Reproducibility and data reusability in life-science research hinge on structured experimental metadata. However, most publications embed sampleâ€toâ€parameter relationships in free-text methods and supplemental tables, making large-scale mining arduous. This challenge invites participants to build models or prompts that, given the plain-text of a scientific article, either reconstruct its Sample Data Relation File (SDRF) or at the very least identify the named entities present: a table whose rows represent individual samples and whose columns correspond to annotation classes (e.g., organism, instrument, strain, ect..). An effective solution will accelerate systematic meta-analysis across thousands of publications.

## **Hackathon Overview**  
There are two parts to this hackathon. In the first part you will attempt to reproduce the annotated metadata from a hand curated training set of 107 proteomics publications using any model/pipeline of your choice. In the second part you will apply your model to a set of publications lacking metadata annotations. 

## **Part #1 Train your model**
Build a custom model or pipeline that meets, or surpasses, the performance of the GPT-o4-mini benchmark on gold-standard SDRF annotations.  

- **Core Task**: Automatically identify every text span in a publication that corresponds to metadata annotations, and assign each span to one of our 71 predefined annotation categories.

- **Bonus Goal**: Go beyond span-level tagging and generate a fully populated SDRF file (tab-delimited format), ready for downstream analysis.

- **Evaluation**: Compute the precision, recall, F1-score for your model results compared to the SDRF. You can test the performance of your model using the interactive python notebooks located [src/data/Performance/](src/data/Performance/).   
   * To test the results of a model/algorithm that outputs a minimal-annotation files use the [src/data/Performance/MinimalAnnotation_Performance_relative2_SDRF.ipynb](src/data/Performance/MinimalAnnotation_Performance_relative2_SDRF.ipynb) Jupyter notebook.  
   * To test the results of a model/algorithm that outputs a full SDRF file use the [src/data/Performance/Predicted-SDRF_Performance_relative2_GS-SDRF.ipynb](src/data/Performance/Predicted-SDRF_Performance_relative2_GS-SDRF.ipynb) Jupyter notebook.  
        
- **Success Metric**: Your solution should match or outperform GPT-o4-mini on a held-out test set of annotated SDRF files.


**Data Provided**  
We have provided the following three key datasets 
1. [The cleaned abstract and methods sections texts from the 100 proteomics publications with gold standard metadata already annotated.](data/CleanText/Training/)  
2. [The Sample Data Relation File (SDRF) containing the gold standard metadata annotations.](data/GoldStandard_SDRFs/) 
3. [A benchmark set of annotations done by the GPT-o4-mini model.](data/BenchmarkAnnotations/o4-mini-2025-04-16/)


## **Part #2 Apply the trained model to unseen data**
Assess how well your trained model generalizes by applying it to completely unseen examples and benchmarking its performance against the training results.

- **Core Tasks**: 
   1. In [BRAT](https://brat.nlplab.org/), manually annotate the Abstract and Methods sections of 10 recently published proteomics papers using our 30-category schema. 
      - For more details about how BRAT works see their [introduction](https://brat.nlplab.org/introduction.html) and [manual](https://brat.nlplab.org/manual.html). 
      - You do not need to install anything and can access the Unseen publications for annotation: [ISMB Collaberation Fest Unseen Annotation Platform](https://cambridge-weak-low-keyword.trycloudflare.com/index.xhtml#/).
         - Read the tutorial popup and then click "OK".  
         - In the file browser that should be present navigate to ISMB/ and select one of the folders named Unseen_CleanText_Copy#. 
         - Each folder contains the same publications to annotate. 
         - If someone else has already started annotating the publications in a directory please do not over write their annotations and fine a clean directory. 
         - Hover your cursor over the brat logo in the upper right corner untill the login button apears. (Username: ISMB; password: 2025)
         - Once logged in you can annotate each document by highlighting text spans and choosing from one of the [annotation types](data/AnnotatedTypes.txt).  
         - You can download your annotations by hovering over the top left banner until the Data button appears and gives you the option to Export the collection with your annotations.  
   2.  Run your model on these new annotations to generate predicted spans and categories.

- **Bonus Goal**: Use both the [PRIDE](https://www.ebi.ac.uk/pride/)/[proteomexchange](https://www.proteomexchange.org/) with the publication to generate [lesSDRF](https://lessdrf.streamlit.app/) annotation files for the Unseen publications. 

- **Evaluation**: Compute the precision, recall, F1-score for your model results compared to the SDRF. You can test the performance of your model using the interactive python notebooks located [src/data/Performance/](src/data/Performance/).   
   * To test the results of a model/algorithm that outputs a minimal-annotation files use the [src/data/Performance/MinimalAnnotation_Performance_relative2_SDRF.ipynb](src/data/Performance/MinimalAnnotation_Performance_relative2_SDRF.ipynb) Jupyter notebook.  
   * To test the results of a model/algorithm that outputs a full SDRF file use the [src/data/Performance/Predicted-SDRF_Performance_relative2_GS-SDRF.ipynb](src/data/Performance/Predicted-SDRF_Performance_relative2_GS-SDRF.ipynb) Jupyter notebook.  

- **Success Metric**: Your modelâ€™s performance on these unseen papers should matchâ€”or exceedâ€”its performance on the original training set.

**Data Provided**  
We have provided the following three key datasets 
1. [The cleaned abstract and methods sections texts from 100 PXDs with no SDRF present](data/CleanText/Unseen/)   

## How to Submit Your Results

When youâ€™ve completed your analysis and are ready to share your work, please submit a **Pull Request (PR)** against this repository following the steps below:

1. **Fork this repository**  
   - Click â€œForkâ€ in the top-right corner to create your own copy under your GitHub account.

2. **Clone your fork locally**  
   ```bash
   git clone https://github.com/<your-username>/<repo-name>.git
   cd <repo-name>
   ```

3. **Create a new branch**  
   - Use a clear, descriptive name. We recommend:  
     ```
     git checkout -b results/<team-name>
     ```  
   - If youâ€™re working solo, replace `<team-name>` with your GitHub username.

4. **Add your results**  
   - Place your result files (notebooks, figures, CSVs, etc.) into the `submissions/` directory.  
   - If your results span multiple files, create a subfolder named after your team:
     ```
     submissions/<team-name>/
       â”œâ”€ analysis.ipynb
       â”œâ”€ figures/
       â””â”€ README.md        â† (brief explanation of your files)
     ```

5. **Commit your changes**  
   ```bash
   git add submissions/<team-name>/
   git commit -m "Add results for <team-name>: <one-line summary>"
   ```

6. **Push your branch to your fork**  
   ```bash
   git push origin results/<team-name>
   ```

7. **Open a Pull Request**  
   - Go to the original contest repo on GitHub.  
   - You should see a banner prompting you to open a PR from `results/<team-name>`.  
   - Click **Compare & pull request**.

8. **Fill out the PR template**  
   In your PR description, please include:
   - **Team name**  
   - **Primary contact GitHub handle**  
   - **Summary of your approach** (2â€“3 sentences)  
   - **List of files/folders** youâ€™re submitting  
   - **Any special instructions** for running your code (e.g. environment, dependencies)

9. **Submit before the deadline**  
   - All PRs must be opened **by 11:59 PM UTC** on the contest end date.  
   - Late submissions may not be reviewed.

10. **After submission**  
    - Monitor your PR for any reviewer comments.  
    - You may push additional commits to the same branch; they will appear in your open PR.

If you encounter any issues with forking, branching, or PRs, please open an issue in this repo or ping one of the organizers on Slack. Good luck, and we look forward to your submissions! ğŸš€




## Other Technical Information  
### Structure of a Sample Data Relation File (SDRF)
An SDRF-Proteomics file is a single table where each row represents one sampleâ€“data file relationship. Columns can have the following headers:  
| Prefix                  | Indicatesâ€¦                                                                |
| ----------------------- | ------------------------------------------------------------------------- |
| **Source Name**         | Unique ID for the *starting material* (e.g. organism)                     |
| **Characteristics\[â€¦]** | Sample attributes (e.g. organism, tissue, disease)                        |
| **Factor Value\[â€¦]**    | Study variables or experimental factors (e.g. treatment, time point)      |
| **Comment\[â€¦]**         | Data-file or technical metadata (e.g. instrument, fraction, label)        |
| **Assay Name**          | Unique ID for the *assay* (i.e. the combination of sample + file)         |
| **Raw Data File**       | File name or path of the raw spectrum file                                |
| *(or)* **Data File**    | Processed output (e.g. mzML, mzTab)                                       |
  

### Characteristics â€” sampleâ€level metadata  
| Annotation Type                  | Definition                                                                                        |
| -------------------------------- | ------------------------------------------------------------------------------------------------- |
| **Age**                          | Age of the donor or developmental stage of the organism (e.g. â€œ45 yearsâ€, â€œE14.5 embryoâ€).        |             
| **AnatomicSiteTumor**            | Anatomical location from which a tumor sample was taken (e.g. â€œleft lung lobeâ€).                  |
| **AncestryCategory**             | Donor ancestry or ethnicity category (e.g. â€œEuropeanâ€, â€œEast Asianâ€).                             |
| **Bait**                         | The protein or molecule used as bait in an affinityâ€purification experiment.                      |
| **BMI**                          | Bodyâ€Mass Index of the donor (kg/mÂ²).                                                             |
| **BiologicalReplicate**          | Identifier for biological replicates (e.g. â€œbioRep1â€, â€œbioRep2â€).                                 |
| **CellLine**                     | Name of the immortalized cell line (e.g. â€œHEK293Tâ€, â€œU2OSâ€).                                      |
| **CellPart**                     | Subcellular compartment or fraction (e.g. â€œnucleusâ€, â€œmitochondriaâ€).                             |
| **CellType**                     | Primary cell type or lineage (e.g. â€œneuronsâ€, â€œfibroblastsâ€).                                     |
| **CleavageAgent**                | Protease or chemical used to digest proteins (e.g. â€œtrypsinâ€, â€œchymotrypsinâ€).                    |
| **Compound**                     | Chemical or small molecule added to the sample (e.g. drug, inhibitor)                             |
| **ConcentrationOfCompound**      | Concentration of the Compound used (e.g. â€œ10 ÂµMâ€).                                                |
| **Depletion**                    | Method used to remove highâ€abundance proteins (e.g. â€œalbumin depletion kitâ€).                     |
| **DevelopmentalStage**           | Stage of development for the sample source (e.g. â€œadultâ€, â€œP7 pupâ€).                              |
| **Disease**                      | Disease state or diagnosis (e.g. â€œbreast cancerâ€, â€œType 2 diabetesâ€).                             |
| **DiseaseTreatment**             | Preâ€treatment applied to diseased samples (e.g. â€œchemotherapyâ€, â€œradiationâ€).                     |
| **GeneticModification**          | Any genetic alteration in the source organism/cells (e.g. â€œGFPâ€taggedâ€, â€œknockout of gene Xâ€).    |
| **Genotype**                     | Genotypic background (e.g. â€œC57BL/6Jâ€, â€œBRCA1-mutantâ€).                                           |
| **GrowthRate**                   | Doubling time or growth rate of cell cultures (e.g. â€œ24 h doublingâ€).                             |
| **Label**                        | Isobaric or metabolic label applied (e.g. â€œTMT-126â€, â€œSILAC heavyâ€).                              |
| **MaterialType**                 | Broad class of material (e.g. â€œtissueâ€, â€œcell lineâ€, â€œbiofluidâ€).                                 |
| **Modification**                 | Postâ€translational modification enrichment or tagging (e.g. â€œphosphorylationâ€, â€œubiquitinationâ€). |
| **NumberOfBiologicalReplicates**\* | Total number of biological replicates in the study.                                               |
| **NumberOfSamples**\*              | Total number of samples processed.                                                                |
| **NumberOfTechnicalReplicates**\*  | Total number of technical replicates per sample.                                                  |
| **Organism**                     | Source species (NCBI Taxonomy ID and name, e.g. â€œ9606 (Homo sapiens)â€).                           |
| **OrganismPart**                 | Tissue or organ of origin (Uberon term, e.g. â€œUBERON:0002107 (liver)â€).                           |
| **OriginSiteDisease**            | Anatomical site of disease origin (e.g. â€œcolonâ€, â€œprostateâ€).                                     |
| **PooledSample**                 | Indicates if multiple samples were pooled (e.g. â€œpool1 of reps1â€“3â€).                              |
| **ReductionReagent**             | Chemical used to reduce disulfide bonds (e.g. â€œDTTâ€, â€œTCEPâ€).                                     |
| **SamplingTime**                 | Time point of sample collection (e.g. â€œT0â€, â€œ24 h postâ€treatmentâ€).                               |
| **SampleTreatment**              | Any treatment applied to the sample before processing (e.g. â€œfixationâ€, â€œlysis buffer Xâ€).        |
| **Sex**                          | Donor sex (e.g. â€œmaleâ€, â€œfemaleâ€).                                                                |
| **Specimen**                     | Description of biological specimen (e.g. â€œbiopsyâ€, â€œplasmaâ€).                                     |
| **SpikedCompound**               | Exogenous standard or spikeâ€in added (e.g. â€œiRT peptidesâ€).                                       |
| **Staining**                     | Any staining applied (e.g. â€œCoomassie Blueâ€, â€œSilver stainâ€).                                     |
| **Strain**                       | Animal strain (e.g. â€œBALB/câ€, â€œFVB/Nâ€).                                                           |
| **SyntheticPeptide**             | Indicates a synthetic peptide sample (e.g. â€œsynthetic phosphopeptideâ€).                           |
| **TumorCellularity**             | Percentage of tumor cells in the sample (e.g. â€œ80%â€).                                             |
| **TumorGrade**                   | Histological grade (e.g. â€œGrade IIâ€).                                                             |
| **TumorSize**                    | Physical size of the tumor (e.g. â€œ3 cm diameterâ€).                                                |
| **TumorSite**                    | Anatomical site of tumor (e.g. â€œbreastâ€, â€œpancreasâ€).                                             |
| **TumorStage**                   | Clinical staging (e.g. â€œStage IIIâ€).                                                              |
| **Time**                         | Broad time parameter (e.g. â€œday 5â€, â€œweek 2â€).                                                    |
| **Temperature**                  | Temperature during processing or incubation (e.g. â€œ37 Â°Câ€).                                       |
| **Treatment**                    | Experimental treatment (e.g. â€œdrug X 5 ÂµM 24â€‰hâ€).                                                 |
\* Not applicable on a per sample basis  

### Comment â€” dataâ€file and protocol parameters  
| Annotation Type             | Definition                                                                |
| --------------------------- | ------------------------------------------------------------------------- |
| **AcquisitionMethod**       | MS acquisition scheme (e.g. â€œDDAâ€, â€œDIAâ€, â€œPRMâ€).                         |
| **CollisionEnergy**         | Collision energy applied in MS/MS (e.g. â€œ27 eVâ€).                         |
| **EnrichmentMethod**        | Peptide/enrichment protocol used (e.g. â€œTiOâ‚‚ phosphopeptide enrichmentâ€). |
| **Experiment**              | Logical grouping or experiment identifier (e.g. â€œexp1â€).                  |
| **FlowRateChromatogram**    | LC flow rate (e.g. â€œ300 nL/minâ€).                                         |
| **FractionationMethod**     | Method used to fractionate peptides (e.g. â€œhigh-pH RP HPLCâ€).             |
| **FractionIdentifier**      | Numeric or text ID of each fraction (e.g. â€œF1â€, â€œF2â€).                    |
| **FragmentationMethod**     | Ionâ€fragmentation technique (e.g. â€œHCDâ€, â€œCIDâ€, â€œETDâ€).                   |
| **FragmentMassTolerance**   | Mass tolerance for fragment matching (e.g. â€œ0.02 Daâ€).                    |
| **GradientTime**            | Total LC gradient length (e.g. â€œ120 minâ€).                                |
| **Instrument**              | Mass spec make/model (e.g. â€œThermo Q-Exactive Plusâ€).                     |
| **IonizationType**          | Ionization source (e.g. â€œnanoESIâ€, â€œMALDIâ€).                              |
| **MS2MassAnalyzer**         | Analyzer used for MS2 (e.g. â€œorbitrapâ€, â€œion trapâ€).                      |
| **NumberOfMissedCleavages** | Max missed cleavages allowed in database search (e.g. â€œ2â€).               |
| **NumberOfFractions**       | Total number of fractions generated from each sample.                     |
| **PrecursorMassTolerance**  | Mass tolerance for precursor matching (e.g. â€œ10 ppmâ€).                    |
| **Separation**              | Chromatographic separation mode (e.g. â€œC18 reversed-phaseâ€).              |

More details about specific annotation types can be found here: [SDRF_Proteomics_Specification_v1.0.0.pdf](../documents/SDRF_Proteomics_Specification_v1.0.0.pdf)     
Note: Most of the sample characteristics and comments above are detailed in this .pdf file but not all. These are an expanded set of annotated tags we use to ensure we get as much metadata from the manuscript as possible and some may not be applicable on a per sample basis (such as NumberBiologicalReplicates).  

## References and Resources
[1] Perez-Riverol Y; European Bioinformatics Community for Mass Spectrometry. Toward a Sample Metadata Standard in Public Proteomics Repositories. J Proteome Res. 2020 Oct 2;19(10):3906-3909. doi: 10.1021/acs.jproteome.0c00376. Epub 2020 Sep 22. PMID: 32786688; PMCID: PMC7116434. [link](https://pmc.ncbi.nlm.nih.gov/articles/PMC7116434/?utm_source=chatgpt.com)  
[2] [www.psidev.info/sdrf-sample-data-relationship-format](www.psidev.info/sdrf-sample-data-relationship-format)  
[3] [https://github.com/CompOmics](https://github.com/CompOmics)  
[4] [https://github.com/bigbio/proteomics-sample-metadata](https://github.com/bigbio/proteomics-sample-metadata)  
[5] Claeys, T., Van Den Bossche, T., Perez-Riverol, Y. et al. lesSDRF is more: maximizing the value of proteomics data through streamlined metadata annotation. Nat Commun 14, 6743 (2023). https://doi.org/10.1038/s41467-023-42543-5